focus -WSS

focus

author：explore 2025-10-01 00:52:25 - browse：9382

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The release of Novo Nordisk’s latest earnings report on Thursday provided a chance for executives to tout their major win this week — outcomes from a large trial showing the company’s obesity drug Wegovy cut the risk of heart complications by 20%.

But once again, much of the attention was focused on the company’s struggles to meet what Novo CEO Lars Fruergaard Jørgensen referred to as the “overwhelming demand for Wegovy.”

Jørgensen reiterated that the company was racing to expand supply and had brought on more contract manufacturing support, but Novo said Thursday that the company would continue to restrict the availability of lower-strength starter doses in the United States to ensure that patients on the drug would not have their medication interrupted.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

WSS

PrEP can help anyone prevent HIV. Why do so few people take it?

CDC: Cases of alpha

FDA approves first blood sugar monitor without finger pricks

Alexander Hamilton and the argument for universal insurance

New requirements coming in 2024 for Americans traveling to Europe

My chronic pain journey would have been easier knowing 5 things % STAT

knowledge

focus

Wikipedia

Hepatitis C has a cure — but many Americans still lack access to it

'The boss' wants server deleted: New allegations emerge in Trump indictment

New air purifier tech could be key to improving indoor air quality

4 missing after record

Anesthesiologist group: stop taking Ozempic before surgery

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Supreme Court strikes down use of affirmative action

Biden to sign 'historic' executive order on how US military handles sexual assault cases

Medical leaders decry Supreme Court decision on affirmative action

FAMU bans football players from facility after release of rap video shot in team's locker room

explore

Will biotech layoffs continue through 2023?

Alexander Hamilton and the argument for universal insurance

Interest rates are at a 22

Sophia Smith scores twice for US in in 3

VC firm RA Capital starts a new synthetic biology incubator

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

focus

leisure time

focus

hotspot